That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

According to researchers, medical training has reached a stage where students know more, but understand less. Although there ...

Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...

NeurIPS 2025, Booth #732 ? MathWorks, the leading developer of mathematical computing software, will showcase how engineers and scientists can use MATLAB® and Simulink® to design, verify, and deploy ...

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...

Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...

A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.